WYETH for WYETH

Copyright/Patent/Trademark CPT

Monitor U.S. trade policies relating to intellectual property protection under the WTO/TRIPS agreement health care reform legislation

Contacted: White House Office; Natl Security Council (NSC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Treasury, Dept of; Natl Security Agency (NSA); U.S. Trade Representative (USTR); Justice, Dept of (DOJ); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); State, Dept of (DOS); SENATE

Trade (domestic/foreign) TRD

Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement Importation of FDA-approved pharmaceuticals

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Justice, Dept of (DOJ); State, Dept of (DOS); Natl Security Agency (NSA); Natl Security Council (NSC); SENATE; HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Treasury, Dept of; Executive Office of the President (EOP); White House Office

Taxation/Internal Revenue Code TAX

Taxation of International Operations of U.S. corporations generally; Homeland investment legislation; R&D tax credit; repatriation of foreign source income; deferral of U.S. taxation of foreign source income

Contacted: Natl Security Council (NSC); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Treasury, Dept of; Office of the Vice President of the United States; Natl Security Agency (NSA); Food & Drug Administration (FDA); White House Office

Health Issues HCR

Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs

Contacted: Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Treasury, Dept of; Executive Office of the President (EOP); Natl Security Council (NSC); Natl Security Agency (NSA); Justice, Dept of (DOJ); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE

Bills named: S. 501 (111th), H.R. 1 (111th), H.R. 1548 (111th), H.R. 1427 (111th), H.R. 573 (111th), S. 301 (111th), S. 525 (111th), S. 369 (111th), H.R. 1706 (111th), H.R. 579 (111th), S. 357 (111th), H.R. 1298 (111th)

Medicare/Medicaid MMM

Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009

Contacted: SENATE; Natl Security Agency (NSA); Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Justice, Dept of (DOJ); Treasury, Dept of; Office of the Vice President of the United States; U.S. Trade Representative (USTR); State, Dept of (DOS); Food & Drug Administration (FDA); Natl Security Council (NSC); HOUSE OF REPRESENTATIVES

Bills named: S. 266 (111th), S. 547 (111th), H.R. 684 (111th), S. 330 (111th), H.R. 1725 (111th), H.R. 904 (111th), S. 301 (111th)

Consumer Issues/Safety/Products CSP

FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal

Contacted: Justice, Dept of (DOJ); Natl Security Agency (NSA); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Office of the Vice President of the United States; Natl Security Council (NSC); White House Office; SENATE; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Treasury, Dept of; Food & Drug Administration (FDA)

Bills named: H.R. 1259 (111th)

Pharmacy PHA

S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act

Contacted: Natl Security Council (NSC); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Natl Security Agency (NSA); White House Office; SENATE; Executive Office of the President (EOP); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Office of the Vice President of the United States

Bills named: S. 510 (111th), H.R. 1427 (111th), H.R. 1548 (111th), S. 726 (111th), H.R. 759 (111th)